Head-to-Head

Abbott Laboratories vs. Crescent Biopharma, Inc. Common Stock

ABT

Abbott Laboratories

$106.20 +1.56%

VS CBIO

Crescent Biopharma, Inc. Common Stock

$14.07 +4.22%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTCBIO
Market Cap $183.77 billion $501.48 million

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTCBIO
Dividend Yield 2.37% —

ABT and CBIO split the dividend factors evenly.

Risk & Sentiment

ABTCBIO
Short Interest 0.57% 1.64%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, CBIO overview, CBIO financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.